A Smoke Free Campus: Lessons Learned from AUB

Policy Series: Tobacco Control Research #

Dataset for: Tobacco Industry Messaging around Harm: Narrative Framing in PMI and BAT Press Releases and Annual Reports 2011 to 2021

This dataset includes Annual Reports and Press releases from British American Tobacco and Philip Morris International published between 2011 and 2021 containing one or more of the keywords: harm, risk, HTP, heat, e-cig/e-cigarette, vap and any of their variants. The data was qualitatively coded using an existing codebook, which is also included in the dataset. The dataset relates to corporate communications around harm and risk, and was collected in order to understand how particular narrative frames might interfere with public health policy relating to tobacco

Data from: A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco products.

Excel spreadsheet of evidence data - coded for relevance, publication status, independence and declaration of conflict of interest

Dataset for "Identifying misleading corporate narratives: The application of linguistic and qualitative methods to commercial determinants of health research"

This dataset concerns the language used by Philip Morris international (PMI) in their external communications. The dataset was collected in order to identify patterns in language used in different corporate communications. This dataset includes Annual Reports, Investor reports, Investor day slide decks, transcripts and reports. It is a record of the inductive coding conducted for this project. The dataset contains the final codebook, which was agreed and approved by all coders

Dataset for ‘Views about integrated smoking cessation and IAPT treatment’

Data included in this dataset contains transcripts of in-depth interviews with psychological wellbeing practitioners (PWPs), Improving Access to Psychological Therapies (IAPT) patients, and stop smoking advisors recruited from IAPT and smoking cessation services in England. Interviews aimed to understand stakeholders’ views about integrating smoking cessation treatment into outpatient psychological services for common mental illness

Dataset for ‘Views about integrated smoking cessation and IAPT treatment’

Data included in this dataset contains transcripts of in-depth interviews with psychological wellbeing practitioners (PWPs), Improving Access to Psychological Therapies (IAPT) patients, and stop smoking advisors recruited from IAPT and smoking cessation services in England. Interviews aimed to understand stakeholders’ views about integrating smoking cessation treatment into outpatient psychological services for common mental illness

Framework Index for "Tobacco Control Legislation in Small Island Nations: Adoption of WHO FCTC Article 13 in the Federated States of Micronesia"

Framework index of the current tobacco advertising, promotion and sponsorship policy (TAPS) environment in the Federated States of Micronesia (FSM). Three research questions underpinned this study: What is the context surrounding the current TAPS policy in FSM? What circumstances led to the development of the current legislative text? And, What is the involvement of the different actors in developing and monitoring the TAPS legislation? A health policy triangle model was used as a conceptual approach on publicly available documents. The thematic framework approach informed the analysis of thirty nine documents. Four themes generated from the analysis: 1) the adoption of TAPS provisions due to international commitments, 2) the limited involvement of sub-national actors, 3) the problematic tobacco control program’s funding and administration and 4) the incomplete documentation of TAPS. This file provides the coded text used for the generated findings, stratified per theme, sub-theme and category. Links to original material are provided in the reference list

Data set for "A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups"

This dataset contains all payments from external donors received by health related All-Party Parliamentary Groups (APPGs) between 2012-2018. Additional tabs within the dataset look specifically at payments made by pharmaceutical companies, payments made by patient organisations funded by pharmaceutical companies, and payments made by pharmaceutical companies to patient organisations which supported APPGs

Data set for "A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups"

This dataset contains all payments from external donors received by health related All-Party Parliamentary Groups (APPGs) between 2012-2018. Additional tabs within the dataset look specifically at payments made by pharmaceutical companies, payments made by patient organisations funded by pharmaceutical companies, and payments made by pharmaceutical companies to patient organisations which supported APPGs

Underreporting of drug industry payments to patient organisations in the UK (2012-2016)

This online dataset comprises web supplements (WS) accompanying the paper entitled “An underreported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016)”. The dataset includes aggregated information from 1. yearly disclosure reports published by 63 UK-based drug companies including payments made to patient organisations; 2. yearly financial accounts produced by 200 UK-based charities and published on charity regulator websites. The data is divided into web supplements 3-20 which are signposted throughout the Results section of the above-mentioned article as “web supplement XX”